Our conference will be composed of four panel discussions and two company presentation sessions showcasing the pipeline of select biotech companies we represent throughout the day.

During our last in-person event in 2020, members and senior executives from more than 600 public & private healthcare companies across the biopharmaceuticals, IVD, medical device, and healthcare services sectors attended our conference. More than 300 PE and VC investors from over 100 firms were also present.